Alpha Synuclein and Vesicular Monoamine Transporter2 Expression Modulate the Vulnerability of Nigral Neurons to Dopaminergic Neurotoxicants

Kennie Raviie Shepherd,Min Z. Wang,E. Danielle Dean,Gary W. Miller

DOI: https://doi.org/10.1096/fasebj.22.1_supplement.715.5

2008-01-01

Abstract:The vesicular monoamine transporter2 (VMAT2) and α‐synuclein are two abundant proteins in the nigrostriatal system, which has been suggested to be responsible for proper maintenance and homeostasis of the dopaminergic system. VMAT2 is responsible for the packaging of dopamine (DA), preventing its degradation and subsequent production of ROS. α‐synuclein has been shown to be a key regulator of VMAT2, and mutations in α‐synuclein have been shown to cause a rare form of Parkinson's disease (PD). Primary nigra neurons isolated from VMAT2 low expresser mice have significant production of ROS, caspase‐3 activation, and undergo retrograde degeneration as demonstrated by a 33.4% loss of tyrosine hydroxylase (TH) positive neurons and processes (66.5%) after the exposure to DA (10μM). In addition, primary cultures generated from mice with differential expression of α‐synuclein and VMAT2 were treated with rotenone (20nM), and MPP+ (5μM), in the presence of 10μM DA, to determine the role of multiple gene interaction in altering the vulnerability of nigra neurons. Nigral neuron vulnerability was assessed by counted TH positive neurons/processes, DCF staining, and caspase‐3 activation after neurotoxicant exposure. The results show that α‐synuclein and VMAT2 modulate the toxicity of these toxicants to varying degrees. Supported by U54ES‐012068; 2T32NS007480; and the American Parkinson's Disease Association.